Pharmaceutical giant Johnson & Johnson has agreed to pay $7.8 million to settle a seven-and-a-half-year-old Risperdal lawsuit, the Arkansas Democrat-Gazette reports. The state of Arkansas filed the lawsuit in 2007, alleging that Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, unlawfully marketed its antipsychotic drug Risperdal to Arkansas doctors.
The lawsuit claimed that Johnson & Johnson put patients at risk by not fully disclosing the ...
continue reading...